SLT Holdings’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$267K Sell
3,199
-1,300
-29% -$107K 0.16% 116
2026
Q2
$299K Buy
4,499
+1,275
+40% +$108K 0.18% 110
2026
Q1
$320K Sell
3,224
-875
-21% -$114K 0.22% 98
2025
Q4
$499K Buy
4,099
+1,575
+62% +$198K 0.32% 70
2025
Q3
$283K Buy
2,524
+31
+1% +$3.63K 0.18% 103
2025
Q2
$334K Buy
+2,493
New +$274K 0.25% 70

Other funds holding TMDX

SLT Holdings's TMDX Position: Q3 2026 in Review

SLT Holdings reduced its Transmedics (TMDX) stake by 29% in Q3 2026, selling an estimated $107K and leaving 3,199 shares worth $267K. The position accounts for 0.16% of the portfolio, ranked #116.

SLT Holdings first reported a position in TMDX in Q2 2025 and has held it in 6 quarters since. The position peaked at $499K in Q4 2025. 384 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • SLT Holdings held 3,199 shares of Transmedics worth $267K as of Q3 2026.
  • SLT Holdings sold 1,300 Transmedics shares in Q3 2026, an estimated $107K.
  • Transmedics made up 0.16% of SLT Holdings's portfolio in Q3 2026, its #116 holding.
  • SLT Holdings first reported a position in Transmedics in Q2 2025 and has held it in 6 quarters since.
  • SLT Holdings's Transmedics position peaked at $499K in Q4 2025.
  • 384 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on SLT Holdings's 13F filing for Q3 2026, filed 15 Oct 2026.